Table 2.
Genotype | Case (n = 407) |
Control (n = 407) |
asOR (95% CI)a | p-value | |
-3444 C>T | CC | 141 | 140 | 1 | |
CT | 201 | 205 | 0.97 (0.72 – 1.32) | 0.86 | |
TT | 65 | 62 | 1.04 (0.68 – 1.58) | 0.85 | |
CT+TT | 266 | 267 | 0.99 (0.74 – 1.32) | 0.94 | |
CC+CT | 342 | 345 | 1 | ||
TT | 65 | 62 | 1.06 (0.72 – 1.55) | 0.77 | |
-1985 G>T | GG | 144 | 140 | 1 | |
GT | 196 | 205 | 0.93 (0.69 – 1.26) | 0.64 | |
TT | 67 | 62 | 1.05 (0.69 – 1.59) | 0.82 | |
GT+TT | 263 | 267 | 0.96 (0.72, 1.28) | 0.77 | |
GG+GT | 340 | 345 | 1 | ||
TT | 67 | 62 | 1.10 (0.75-1.60) | 0.63 | |
I655V A>G | AA | 304 | 300 | 1 | |
AG | 97 | 97 | 0.99 (0.71 – 1.36) | 0.93 | |
GG | 5 | 6 | 0.82 (0.25 – 2.72) | 0.75 | |
AG+GG | 102 | 103 | 0.98 (0.71 – 1.34) | 0.88 | |
AA+AG | 401 | 397 | 1 | ||
GG | 5 | 6 | 0.83 (0.25 – 2.73) | 0.75 | |
P1170A C>G | CC | 144 | 137 | 1 | |
CG | 199 | 206 | 0.92 (0.68 – 1.25) | 0.59 | |
GG | 64 | 64 | 0.95 (0.63 – 1.45) | 0.82 | |
CG+GG | 263 | 270 | 0.93 (0.69 – 1.24) | 0.61 | |
CC+CG | 343 | 343 | 1 | ||
GG | 64 | 64 | 1.00 (0.69 – 1.46) | 1 |
OR, odds ratio; CI, confidence interval.
aasOR are adjusted for age and gender.